// App-Quantinova.ai

1834 : Total Hip Arthroplasty Outcomes: A 17 Year Experience in a Single-Center: Is Systemic Lupus Erythematosus a Real Risk Factor for Adverse Outcomes?

Researchers

Presenter

  • Marco Gonzalez-Contreras

Principal Investigators

  • Javier Merayo-Chalico

  • Rigoberto Ortiz-Hernandez

  • Diana Gomez-Martin

  • Jorge Alcocer-Varela

Medical Centers

  • Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico city, Mexico

  • Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico city, Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Rheumatoid arthritis

  • Osteoarthritis

  • Venous thrombosis

  • Inflammatory Arthritis

  • Hematoma

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim